Jamaica

Jamaica

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.27 (0.24 - 0.30) 2019 Modelled IHME
0.27 (0.24 - 0.30) 2018 Modelled IHME
0.27 (0.24 - 0.31) 2017 Modelled IHME
0.28 (0.25 - 0.32) 2016 Modelled IHME
0.29 (0.25 - 0.33) 2015 Modelled IHME
0.3 (0.26 - 0.34) 2014 Modelled IHME
0.3 (0.27 - 0.34) 2013 Modelled IHME
0.31 (0.27 - 0.35) 2012 Modelled IHME
0.31 (0.27 - 0.36) 2011 Modelled IHME
0.32 (0.28 - 0.37) 2010 Modelled IHME
0.33 (0.28 - 0.37) 2009 Modelled IHME
0.33 (0.29 - 0.38) 2008 Modelled IHME
0.34 (0.29 - 0.39) 2007 Modelled IHME
0.35 (0.29 - 0.40) 2006 Modelled IHME
0.35 (0.30 - 0.40) 2005 Modelled IHME
0.36 (0.30 - 0.41) 2004 Modelled IHME
0.36 (0.31 - 0.41) 2003 Modelled IHME
0.36 (0.31 - 0.42) 2002 Modelled IHME
0.37 (0.31 - 0.42) 2001 Modelled IHME
0.37 (0.32 - 0.43) 2000 Modelled IHME
0.37 (0.32 - 0.43) 1999 Modelled IHME
0.37 (0.32 - 0.43) 1998 Modelled IHME
0.38 (0.32 - 0.44) 1997 Modelled IHME
0.38 (0.32 - 0.44) 1996 Modelled IHME
0.38 (0.32 - 0.44) 1995 Modelled IHME
0.39 (0.33 - 0.45) 1994 Modelled IHME
0.39 (0.33 - 0.45) 1993 Modelled IHME
0.39 (0.33 - 0.46) 1992 Modelled IHME
0.4 (0.33 - 0.46) 1991 Modelled IHME
0.4 (0.34 - 0.47) 1990 Modelled IHME
0.49 (0.11 - 1.41) 2015 Modelled WHO
5 (2.40 - 5.70) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.01 (0.01 - 0.02) 2019 Modelled IHME
0.01 (0.01 - 0.02) 2018 Modelled IHME
0.01 (0.01 - 0.02) 2017 Modelled IHME
0.01 (0.01 - 0.02) 2016 Modelled IHME
0.02 (0.01 - 0.02) 2015 Modelled IHME
0.02 (0.01 - 0.02) 2014 Modelled IHME
0.02 (0.01 - 0.02) 2013 Modelled IHME
0.02 (0.01 - 0.03) 2012 Modelled IHME
0.02 (0.01 - 0.03) 2011 Modelled IHME
0.02 (0.02 - 0.03) 2010 Modelled IHME
0.03 (0.02 - 0.03) 2009 Modelled IHME
0.03 (0.02 - 0.04) 2008 Modelled IHME
0.03 (0.02 - 0.04) 2007 Modelled IHME
0.04 (0.03 - 0.05) 2006 Modelled IHME
0.04 (0.03 - 0.06) 2005 Modelled IHME
0.06 (0.05 - 0.09) 2004 Modelled IHME
0.1 (0.07 - 0.14) 2003 Modelled IHME
0.14 (0.11 - 0.20) 2002 Modelled IHME
0.18 (0.13 - 0.25) 2001 Modelled IHME
0.2 (0.14 - 0.27) 2000 Modelled IHME
0.2 (0.15 - 0.28) 1999 Modelled IHME
0.21 (0.15 - 0.28) 1998 Modelled IHME
0.21 (0.15 - 0.28) 1997 Modelled IHME
0.21 (0.15 - 0.28) 1996 Modelled IHME
0.22 (0.15 - 0.29) 1995 Modelled IHME
0.22 (0.15 - 0.29) 1994 Modelled IHME
0.22 (0.16 - 0.29) 1993 Modelled IHME
0.22 (0.16 - 0.30) 1992 Modelled IHME
0.23 (0.16 - 0.30) 1991 Modelled IHME
0.23 (0.16 - 0.30) 1990 Modelled IHME
0.16 (0.04 - 0.51) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
9,452 (7,967 - 11,067) 1990 Modelled IHME
9,429 (7,961 - 11,034) 1991 Modelled IHME
9,426 (7,995 - 10,987) 1992 Modelled IHME
9,437 (8,002 - 10,974) 1993 Modelled IHME
9,460 (8,042 - 10,981) 1994 Modelled IHME
9,494 (8,052 - 11,030) 1995 Modelled IHME
9,540 (8,124 - 11,071) 1996 Modelled IHME
9,591 (8,159 - 11,104) 1997 Modelled IHME
9,641 (8,209 - 11,150) 1998 Modelled IHME
9,680 (8,244 - 11,209) 1999 Modelled IHME
9,700 (8,263 - 11,278) 2000 Modelled IHME
9,700 (8,290 - 11,180) 2001 Modelled IHME
9,682 (8,261 - 11,107) 2002 Modelled IHME
9,646 (8,218 - 11,047) 2003 Modelled IHME
9,593 (8,150 - 11,011) 2004 Modelled IHME
9,523 (8,093 - 10,954) 2005 Modelled IHME
9,424 (8,016 - 10,760) 2006 Modelled IHME
9,289 (7,961 - 10,562) 2007 Modelled IHME
9,130 (7,843 - 10,327) 2008 Modelled IHME
8,963 (7,774 - 10,170) 2009 Modelled IHME
8,805 (7,661 - 10,056) 2010 Modelled IHME
8,663 (7,595 - 9,810) 2011 Modelled IHME
8,525 (7,481 - 9,611) 2012 Modelled IHME
8,388 (7,362 - 9,419) 2013 Modelled IHME
8,239 (7,242 - 9,335) 2014 Modelled IHME
8,073 (7,069 - 9,173) 2015 Modelled IHME
7,849 (6,884 - 8,883) 2016 Modelled IHME
7,667 (6,691 - 8,671) 2017 Modelled IHME
7,581 (6,648 - 8,513) 2018 Modelled IHME
7,546 (6,629 - 8,503) 2019 Modelled IHME
143,000 (69,000 - 164,000) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
1.2 (0.86 - 1.62) 2019 Modelled IHME
1.18 (0.86 - 1.57) 2018 Modelled IHME
1.17 (0.87 - 1.53) 2017 Modelled IHME
1.15 (0.89 - 1.50) 2016 Modelled IHME
1.15 (0.90 - 1.47) 2015 Modelled IHME
1.17 (0.94 - 1.45) 2014 Modelled IHME
1.15 (0.94 - 1.42) 2013 Modelled IHME
1.23 (1 - 1.51) 2012 Modelled IHME
1.41 (1.14 - 1.74) 2011 Modelled IHME
1.33 (1.08 - 1.62) 2010 Modelled IHME
1.5 (1.21 - 1.86) 2009 Modelled IHME
1.43 (1.15 - 1.77) 2008 Modelled IHME
1.23 (0.98 - 1.53) 2007 Modelled IHME
1.07 (0.86 - 1.33) 2006 Modelled IHME
1.05 (0.84 - 1.31) 2005 Modelled IHME
1.1 (0.89 - 1.36) 2004 Modelled IHME
1.17 (0.95 - 1.44) 2003 Modelled IHME
1.21 (0.97 - 1.50) 2002 Modelled IHME
1.21 (0.97 - 1.52) 2001 Modelled IHME
1.2 (0.96 - 1.51) 2000 Modelled IHME
1.27 (1.02 - 1.61) 1999 Modelled IHME
1.31 (1.04 - 1.65) 1998 Modelled IHME
1.35 (1.04 - 1.73) 1997 Modelled IHME
1.4 (1.07 - 1.82) 1996 Modelled IHME
1.41 (1.06 - 1.84) 1995 Modelled IHME
1.52 (1.15 - 1.97) 1994 Modelled IHME
1.57 (1.22 - 2) 1993 Modelled IHME
1.57 (1.25 - 1.98) 1992 Modelled IHME
1.57 (1.26 - 1.94) 1991 Modelled IHME
1.66 (1.34 - 2.05) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
34 (24 - 45) 2019 Modelled IHME
33 (24 - 44) 2018 Modelled IHME
33 (24 - 43) 2017 Modelled IHME
32 (25 - 42) 2016 Modelled IHME
32 (25 - 41) 2015 Modelled IHME
33 (26 - 40) 2014 Modelled IHME
32 (26 - 40) 2013 Modelled IHME
34 (28 - 42) 2012 Modelled IHME
39 (32 - 48) 2011 Modelled IHME
37 (30 - 45) 2010 Modelled IHME
41 (33 - 51) 2009 Modelled IHME
39 (31 - 49) 2008 Modelled IHME
34 (27 - 42) 2007 Modelled IHME
29 (23 - 36) 2006 Modelled IHME
28 (23 - 35) 2005 Modelled IHME
30 (24 - 37) 2004 Modelled IHME
31 (25 - 39) 2003 Modelled IHME
32 (26 - 40) 2002 Modelled IHME
32 (26 - 40) 2001 Modelled IHME
31 (25 - 40) 2000 Modelled IHME
33 (26 - 42) 1999 Modelled IHME
34 (27 - 42) 1998 Modelled IHME
34 (27 - 44) 1997 Modelled IHME
35 (27 - 46) 1996 Modelled IHME
35 (26 - 46) 1995 Modelled IHME
37 (28 - 48) 1994 Modelled IHME
38 (30 - 49) 1993 Modelled IHME
38 (30 - 48) 1992 Modelled IHME
38 (30 - 46) 1991 Modelled IHME
39 (32 - 48) 1990 Modelled IHME
97 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
26 (19 - 34) 2019 Modelled IHME
26 (19 - 34) 2018 Modelled IHME
26 (20 - 35) 2017 Modelled IHME
26 (20 - 35) 2016 Modelled IHME
26 (20 - 35) 2015 Modelled IHME
26 (20 - 35) 2014 Modelled IHME
27 (20 - 35) 2013 Modelled IHME
27 (21 - 36) 2012 Modelled IHME
28 (21 - 37) 2011 Modelled IHME
28 (21 - 37) 2010 Modelled IHME
29 (22 - 37) 2009 Modelled IHME
28 (21 - 37) 2008 Modelled IHME
27 (21 - 36) 2007 Modelled IHME
27 (20 - 36) 2006 Modelled IHME
27 (20 - 36) 2005 Modelled IHME
27 (20 - 36) 2004 Modelled IHME
27 (21 - 36) 2003 Modelled IHME
28 (21 - 36) 2002 Modelled IHME
27 (20 - 36) 2001 Modelled IHME
27 (20 - 36) 2000 Modelled IHME
28 (20 - 37) 1999 Modelled IHME
28 (21 - 37) 1998 Modelled IHME
28 (21 - 37) 1997 Modelled IHME
28 (21 - 37) 1996 Modelled IHME
28 (20 - 37) 1995 Modelled IHME
28 (21 - 37) 1994 Modelled IHME
28 (21 - 37) 1993 Modelled IHME
28 (21 - 37) 1992 Modelled IHME
28 (21 - 37) 1991 Modelled IHME
28 (21 - 37) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
97 2018 Survey/reported WHO/UNICEF
93 2017 Survey/reported WHO/UNICEF
98 2016 Survey/reported WHO/UNICEF
91 2015 Survey/reported WHO/UNICEF
92 2014 Survey/reported WHO/UNICEF
93 2013 Survey/reported WHO/UNICEF
96 2012 Survey/reported WHO/UNICEF
92 2011 Survey/reported WHO/UNICEF
94 2010 Survey/reported WHO/UNICEF
90 2009 Survey/reported WHO/UNICEF
92 2008 Survey/reported WHO/UNICEF
92 2007 Survey/reported WHO/UNICEF
97 2006 Survey/reported WHO/UNICEF
99 2005 Survey/reported WHO/UNICEF
98 2004 Survey/reported WHO/UNICEF
36 2003 Survey/reported WHO/UNICEF
96 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Planned for 2020
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.64 (1.32 - 2.04) 2019 Modelled IHME
1.63 (1.31 - 2.01) 2018 Modelled IHME
1.61 (1.29 - 1.99) 2017 Modelled IHME
1.58 (1.27 - 1.96) 2016 Modelled IHME
1.56 (1.26 - 1.93) 2015 Modelled IHME
1.56 (1.25 - 1.93) 2014 Modelled IHME
1.55 (1.24 - 1.91) 2013 Modelled IHME
1.55 (1.24 - 1.91) 2012 Modelled IHME
1.55 (1.23 - 1.91) 2011 Modelled IHME
1.54 (1.23 - 1.91) 2010 Modelled IHME
1.54 (1.23 - 1.91) 2009 Modelled IHME
1.53 (1.23 - 1.90) 2008 Modelled IHME
1.53 (1.23 - 1.90) 2007 Modelled IHME
1.53 (1.23 - 1.90) 2006 Modelled IHME
1.52 (1.23 - 1.90) 2005 Modelled IHME
1.53 (1.23 - 1.90) 2004 Modelled IHME
1.54 (1.24 - 1.92) 2003 Modelled IHME
1.55 (1.24 - 1.93) 2002 Modelled IHME
1.56 (1.25 - 1.95) 2001 Modelled IHME
1.57 (1.24 - 1.96) 2000 Modelled IHME
1.56 (1.25 - 1.94) 1999 Modelled IHME
1.55 (1.24 - 1.94) 1998 Modelled IHME
1.53 (1.23 - 1.92) 1997 Modelled IHME
1.52 (1.22 - 1.90) 1996 Modelled IHME
1.52 (1.21 - 1.90) 1995 Modelled IHME
1.52 (1.22 - 1.89) 1994 Modelled IHME
1.52 (1.22 - 1.90) 1993 Modelled IHME
1.52 (1.22 - 1.90) 1992 Modelled IHME
1.53 (1.22 - 1.90) 1991 Modelled IHME
1.53 (1.23 - 1.91) 1990 Modelled IHME
Showing out of
Show more

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
36,283 (29,037 - 45,110) 1990 Modelled IHME
36,368 (29,053 - 45,324) 1991 Modelled IHME
36,583 (29,298 - 45,712) 1992 Modelled IHME
36,891 (29,615 - 46,050) 1993 Modelled IHME
37,269 (29,882 - 46,468) 1994 Modelled IHME
37,691 (30,131 - 47,101) 1995 Modelled IHME
38,259 (30,611 - 47,796) 1996 Modelled IHME
39,005 (31,191 - 48,701) 1997 Modelled IHME
39,803 (31,957 - 49,843) 1998 Modelled IHME
40,523 (32,468 - 50,426) 1999 Modelled IHME
41,032 (32,623 - 51,334) 2000 Modelled IHME
41,256 (32,973 - 51,428) 2001 Modelled IHME
41,278 (33,098 - 51,328) 2002 Modelled IHME
41,214 (33,318 - 51,306) 2003 Modelled IHME
41,172 (33,188 - 51,304) 2004 Modelled IHME
41,269 (33,355 - 51,324) 2005 Modelled IHME
41,502 (33,510 - 51,578) 2006 Modelled IHME
41,767 (33,681 - 51,821) 2007 Modelled IHME
42,031 (33,832 - 52,070) 2008 Modelled IHME
42,274 (33,794 - 52,351) 2009 Modelled IHME
42,497 (33,860 - 52,530) 2010 Modelled IHME
42,693 (34,107 - 52,710) 2011 Modelled IHME
42,880 (34,228 - 52,939) 2012 Modelled IHME
43,082 (34,528 - 53,139) 2013 Modelled IHME
43,299 (34,824 - 53,656) 2014 Modelled IHME
43,550 (35,211 - 53,784) 2015 Modelled IHME
44,195 (35,528 - 54,909) 2016 Modelled IHME
45,010 (36,254 - 55,641) 2017 Modelled IHME
45,599 (36,639 - 56,512) 2018 Modelled IHME
46,114 (37,158 - 57,370) 2019 Modelled IHME
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
1.93 (1.37 - 2.62) 2019 Modelled IHME
1.89 (1.36 - 2.56) 2018 Modelled IHME
1.86 (1.38 - 2.47) 2017 Modelled IHME
1.82 (1.40 - 2.39) 2016 Modelled IHME
1.8 (1.41 - 2.29) 2015 Modelled IHME
1.74 (1.39 - 2.19) 2014 Modelled IHME
1.58 (1.27 - 1.97) 2013 Modelled IHME
1.56 (1.26 - 1.93) 2012 Modelled IHME
1.66 (1.33 - 2.08) 2011 Modelled IHME
1.54 (1.22 - 1.92) 2010 Modelled IHME
1.74 (1.35 - 2.16) 2009 Modelled IHME
1.69 (1.32 - 2.11) 2008 Modelled IHME
1.5 (1.18 - 1.89) 2007 Modelled IHME
1.34 (1.04 - 1.67) 2006 Modelled IHME
1.33 (1.04 - 1.68) 2005 Modelled IHME
1.4 (1.11 - 1.76) 2004 Modelled IHME
1.5 (1.20 - 1.88) 2003 Modelled IHME
1.56 (1.24 - 1.95) 2002 Modelled IHME
1.59 (1.25 - 2) 2001 Modelled IHME
1.57 (1.24 - 1.97) 2000 Modelled IHME
1.64 (1.28 - 2.06) 1999 Modelled IHME
1.64 (1.28 - 2.11) 1998 Modelled IHME
1.68 (1.29 - 2.17) 1997 Modelled IHME
1.71 (1.31 - 2.24) 1996 Modelled IHME
1.73 (1.32 - 2.28) 1995 Modelled IHME
1.81 (1.36 - 2.36) 1994 Modelled IHME
1.84 (1.39 - 2.38) 1993 Modelled IHME
1.82 (1.41 - 2.29) 1992 Modelled IHME
1.79 (1.40 - 2.22) 1991 Modelled IHME
1.92 (1.52 - 2.39) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
54 (38 - 74) 2019 Modelled IHME
53 (38 - 72) 2018 Modelled IHME
52 (39 - 69) 2017 Modelled IHME
51 (39 - 67) 2016 Modelled IHME
50 (39 - 64) 2015 Modelled IHME
48 (39 - 61) 2014 Modelled IHME
44 (35 - 55) 2013 Modelled IHME
43 (35 - 54) 2012 Modelled IHME
46 (37 - 57) 2011 Modelled IHME
42 (34 - 53) 2010 Modelled IHME
48 (37 - 59) 2009 Modelled IHME
46 (36 - 58) 2008 Modelled IHME
41 (32 - 52) 2007 Modelled IHME
36 (28 - 45) 2006 Modelled IHME
36 (28 - 46) 2005 Modelled IHME
38 (30 - 47) 2004 Modelled IHME
40 (32 - 50) 2003 Modelled IHME
42 (33 - 52) 2002 Modelled IHME
42 (33 - 53) 2001 Modelled IHME
41 (32 - 52) 2000 Modelled IHME
43 (33 - 53) 1999 Modelled IHME
42 (33 - 54) 1998 Modelled IHME
43 (33 - 55) 1997 Modelled IHME
43 (33 - 56) 1996 Modelled IHME
43 (33 - 57) 1995 Modelled IHME
44 (33 - 58) 1994 Modelled IHME
45 (34 - 58) 1993 Modelled IHME
44 (34 - 55) 1992 Modelled IHME
43 (33 - 53) 1991 Modelled IHME
45 (36 - 57) 1990 Modelled IHME
48 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
24 (17 - 32) 2019 Modelled IHME
24 (17 - 31) 2018 Modelled IHME
24 (17 - 31) 2017 Modelled IHME
24 (17 - 31) 2016 Modelled IHME
24 (17 - 31) 2015 Modelled IHME
24 (18 - 31) 2014 Modelled IHME
24 (18 - 31) 2013 Modelled IHME
24 (17 - 31) 2012 Modelled IHME
23 (17 - 31) 2011 Modelled IHME
24 (17 - 31) 2010 Modelled IHME
23 (16 - 30) 2009 Modelled IHME
23 (17 - 31) 2008 Modelled IHME
24 (17 - 32) 2007 Modelled IHME
25 (18 - 32) 2006 Modelled IHME
25 (18 - 33) 2005 Modelled IHME
25 (18 - 33) 2004 Modelled IHME
25 (18 - 33) 2003 Modelled IHME
25 (18 - 32) 2002 Modelled IHME
25 (18 - 33) 2001 Modelled IHME
25 (17 - 33) 2000 Modelled IHME
24 (17 - 32) 1999 Modelled IHME
24 (17 - 32) 1998 Modelled IHME
24 (17 - 32) 1997 Modelled IHME
24 (17 - 32) 1996 Modelled IHME
24 (17 - 33) 1995 Modelled IHME
25 (17 - 32) 1994 Modelled IHME
25 (17 - 32) 1993 Modelled IHME
25 (18 - 32) 1992 Modelled IHME
25 (18 - 32) 1991 Modelled IHME
24 (17 - 32) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Planned for 2020
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
34
2019
(24 - 45)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
54
2019
(38 - 74)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines